Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy

Danilo Neglia1, Antonio L'Abbate

  • 1Clinical PET Laboratory, CNR Institute of Clinical Physiology, Via G. Moruzzi 1, 56124 Pisa, Italy. dneglia@ifc.cnr.it

Insights

Coronary microvascular dysfunction is an early characteristic of dilated cardiomyopathy (DCM), driving disease progression and predicting poor outcomes. Targeting the coronary microcirculation may offer new therapeutic strategies for heart failure.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Translational Medicine

Background:

  • Coronary microvascular abnormalities are increasingly recognized in cardiac diseases.
  • Dilated cardiomyopathy (DCM) exhibits early coronary microvessel dysfunction.
  • This dysfunction appears to cause, rather than result from, myocardial damage.

Purpose of the Study:

  • To investigate the role of coronary microcirculatory dysfunction in the early stages of DCM.
  • To explore the mechanisms underlying progressive cardiac deterioration in DCM.
  • To assess the prognostic significance of coronary microcirculatory dysfunction in DCM.

Main Methods:

  • The abstract does not specify the methods used.
  • Studies cited demonstrate the presence and extent of coronary microcirculatory dysfunction.
  • Prognostic relevance was assessed in patients with early-stage DCM.

Main Results:

  • Coronary microcirculatory dysfunction is an early feature of DCM.
  • It contributes to progressive contractile impairment, ventricular dilation, and heart failure.
  • Microvascular dysfunction is an independent predictor of worse prognosis in early DCM.

Conclusions:

  • Coronary microcirculation plays a key role in DCM pathogenesis.
  • Myocardial hypoperfusion and ischemia at the microvascular level are likely involved mechanisms.
  • The coronary microcirculation represents a potential therapeutic target for DCM and heart failure risk.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...